8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.85%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.33%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-21.34%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-23.85%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-21.96%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-22.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-22.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.06%
Share count expansion well above 9843.T's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.06%
Diluted share count expanding well above 9843.T's 0.00%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
5.15%
OCF growth at 50-75% of 9843.T's 7.25%. Martin Whitman would question if the firm lags in monetizing sales effectively.
5.15%
FCF growth 50-75% of 9843.T's 7.25%. Martin Whitman would see if structural disadvantages exist in generating free cash.
170.42%
10Y revenue/share CAGR 1.25-1.5x 9843.T's 124.91%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
62.00%
5Y revenue/share CAGR above 1.5x 9843.T's 36.46%. David Dodd would look for consistent product or market expansions fueling outperformance.
34.07%
3Y revenue/share CAGR above 1.5x 9843.T's 4.66%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
99.06%
Net income/share CAGR 1.25-1.5x 9843.T's 86.75%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
23.20%
Positive 5Y CAGR while 9843.T is negative. John Neff might view this as a strong mid-term relative advantage.
-9.07%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
341.28%
10Y equity/share CAGR 1.25-1.5x 9843.T's 267.73%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
88.66%
5Y equity/share CAGR 1.25-1.5x 9843.T's 78.76%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
40.10%
3Y equity/share CAGR similar to 9843.T's 40.50%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
140.00%
10Y dividend/share CAGR at 50-75% of 9843.T's 233.33%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
166.67%
5Y dividend/share CAGR above 1.5x 9843.T's 59.57%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
9.09%
Below 50% of 9843.T's 31.58%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
5.48%
Our AR growth while 9843.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
6.87%
Inventory growth well above 9843.T's 4.46%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.24%
Asset growth well under 50% of 9843.T's 3.83%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.53%
Similar to 9843.T's 2.55%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-5.67%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
2.76%
SG&A growth well above 9843.T's 0.50%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.